Turn Therapeutics Inc. Common Stock Net Asset Momentum
Turn Therapeutics Inc. Common Stock net asset momentum. Turn Therapeutics Inc. Common Stock (TTRX) recorded a net asset momentum of 2741.4% as of December 2025, with net assets of $4.69 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore how well can Turn Therapeutics Inc. Common Stock service its debt to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Turn Therapeutics Inc. Common Stock (2023–2025)
Net asset momentum of Turn Therapeutics Inc. Common Stock from 2023 to 2025. This chart tracks Turn Therapeutics Inc. Common Stock's year-over-year net asset growth across 3 annual reporting periods from 2023 to 2025. The most recent momentum reading is +2741.4%, with net assets of $4.69 Million USD as of December 2025. See Turn Therapeutics Inc. Common Stock shareholders equity for net asset value and shareholders' equity analysis.
Turn Therapeutics Inc. Common Stock Net Asset Momentum by Year (2023–2025)
Turn Therapeutics Inc. Common Stock net asset momentum by year from 2023 to 2025. The table below shows the complete annual net asset history for Turn Therapeutics Inc. Common Stock from 2023 to 2025, covering 3 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see how much is Turn Therapeutics Inc. Common Stock worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $4.69 Million | $12.16 Million | $7.48 Million | ▲ +2741.4% |
| 2024 | $-177.43K | $2.05 Million | $2.23 Million | ▼ -306.9% |
| 2023 | $85.77K | $2.01 Million | $1.93 Million | — |